Engineering Precision Care: Verily’s Strategy and Vision

In this episode of unNatural Selection, produced in partnership with Mass General Brigham for the World Medical Innovation Forum, we sit down with Andrew Trister to explore the evolution of Verily, Alphabet’s precision health company. We discuss Verily’s journey from its early days as an innovation lab to its transformation into a platform company, focused on delivering insights directly into clinical workflows. Andrew shares how Verily is shaping its innovation strategy, with a five-year horizon on the biggest opportunities in connecting health data and driving insights toward precision care. At the heart of this vision is Verily’s objective of building a true health decision platform—one that bridges technology and medicine to redefine how care is delivered.